The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Tue., Sep. 1, 6:04 AM

Slide #4. Intrexon Corporation Secondary Offering

Company: Intrexon Corporation (NYSE:XON)
Date announced: 8/20/2015
Shares Offered: 4,878,049
Date of Pricing: 8/21/2015
Price Per Share: $41.00
Secondary Offering Details: Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today it has commenced an underwritten public offering of shares of its common stock. Intrexon intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of the common stock offered in the public offering. All of the shares in the offering will be sold by Intrexon. -updated 8/21- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has priced its previously announced underwritten public offering of common stock consisting of 4,878,049 shares at a public offering price of $41.00 per share. Gross proceeds to Intrexon from this offering are expected to be approximately $200 million and Intrexon intends to use the net proceeds from this offering for general corporate purposes as well as for strategic acquisitions or investments. Intrexon has granted the underwriters a 30-day option to purchase up to an additional 731,707 shares of common stock offered in the public offering. All of the shares in the offering will be sold by Intrexon. The offering is expected to close on August 26, 2015, subject to customary closing conditions. JMP Securities LLC is acting as sole book-running manager and Stifel is acting as lead manager for the offering. Griffin Securities and Wunderlich Securities are acting as co-managers for the offering.

Intrexon is engaged in the business of synthetic biology. Using its suite of technologies, it design, builds and regulates gene programs, which are deoxyribonucleic acid sequences that consist of genetic components. It is these genetically modified cell systems that can be used to produce proteins, produce small molecules, or serve as cell-based products, which enable the development of new products and manufacturing processes across a range of markets, including healthcare, food, energy and environmental sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery.
Open the XON Page at The Online Investor »

Company Name:  Intrexon Corp
Website:  www.dna.com
Sector:  Biotechnology
Number of ETFs Holding XON:  20
Total Market Value Held by ETFs:  $117.97M
Total Market Capitalization:  $4.92B
% of Market Cap. Held by ETFs:  2.40%
 

Open the XON Page at The Online Investor (in a new window) »

September 1, 2015    6:04 AM Eastern
Quotes delayed 20 minutes



Buy (2.80 out of 4)
30th percentile
(ranked lower than approx. 70% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.